SANUWAVE Health, Inc. (SNWV), our long term holding, has received a patent issued by the U.S. Patent and Trademark Office entitled “Extracorporeal Shock Wave Device.” The claims of the patent (patent number 8,556,813) relate to a new extracorporeal applicator, which creates significant advantages for certain applications. The patent has a term extending to April 2031. […]
Home» Posts tagged "SNWV"
Sanuwave Could Run Up Into Approaching Catalyst
Sanuwave (SNWV) stated that enrollment for the last part of their phase III study of ‘dermaPACE’ is set to begin before the end of Q2 – which is less than 30 days away. This is a huge catalyst for the company’s shares, which have traded completely under the radar thus far. dermaPACE is a device […]